SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-20-000045
Filing Date
2020-07-31
Accepted
2020-07-31 08:43:19
Documents
15
Period of Report
2020-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K anab-20200720.htm   iXBRL 8-K 43280
2 EX-99.01 a07312020pressrelease.htm EX-99.01 10368
  Complete submission text file 0001370053-20-000045.txt   205116

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20200720.xsd EX-101.SCH 2442
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20200720_cal.xml EX-101.CAL 726
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20200720_def.xml EX-101.DEF 1663
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20200720_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20200720_pre.xml EX-101.PRE 13206
8 EXTRACTED XBRL INSTANCE DOCUMENT anab-20200720_htm.xml XML 10949
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 201063743
SIC: 2834 Pharmaceutical Preparations